-
Something wrong with this record ?
Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site
Kuzelová K., Grebenová D., Hrkal Z.
Language English Country United States
NLK
Free Medical Journals
from 2003 to 1 year ago
Wiley Online Library (archiv)
from 1980-01-01 to 2012-12-31
Wiley Free Content
from 2003 to 1 year ago
- MeSH
- Apoptosis MeSH
- Staining and Labeling MeSH
- Amino Acid Chloromethyl Ketones analysis pharmacology metabolism MeSH
- Financing, Organized MeSH
- Fluorescent Dyes analysis metabolism MeSH
- Caspase Inhibitors MeSH
- Caspase 3 MeSH
- Kinetics MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Protein Subunits metabolism MeSH
- Protein Processing, Post-Translational drug effects MeSH
- Propidium MeSH
- Flow Cytometry MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Substrate Specificity MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
BACKGROUND: Fluorochrome-labeled inhibitors of caspases (FLICA) have been designed as an alternative tool for the detection of caspase activation in whole cells. They should label the active site of the corresponding caspase through a covalent attachment to the reactive cysteine residue. METHODS: One of the FLICAs, FAM-DEVD-fmk, was used to monitor apoptosis progression in leukemic JURL-MK1 cells by means of flow cytometry. The effects of unlabeled caspase inhibitors z-DEVD-fmk and z-VAD-fmk on FLICA staining were analyzed to evaluate the contribution of caspase-bound FLICA to the fluorescent signal. Covalent binding of inhibitors to caspase-3 subunit was revealed by Western blotting. RESULTS: Although the unlabeled inhibitors irreversibly bind to caspase-3, completely inhibit its activity, and prevent FLICA binding to caspase-3 even at concentrations lower than 5 muM, they have no effect on FLICA staining of apoptotic cells. CONCLUSIONS: Fluorescent signal of FLICA is characteristic for apoptotic cells but originates mainly from yet unspecified site(s) that differ from the caspase active site. This finding puts in doubt the specificity of staining by various FLICAs with regard to individual caspases and shows the need for an extreme care in the interpretation of data obtained using these labels. Copyright 2007 International Society for Analytical Cytology.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10001075
- 003
- CZ-PrNML
- 005
- 20120910174114.0
- 008
- 100118s2007 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kuželová, Kateřina $7 xx0115456
- 245 10
- $a Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site / $c Kuzelová K., Grebenová D., Hrkal Z.
- 314 __
- $a Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. kuzel@uhkt.cz
- 520 9_
- $a BACKGROUND: Fluorochrome-labeled inhibitors of caspases (FLICA) have been designed as an alternative tool for the detection of caspase activation in whole cells. They should label the active site of the corresponding caspase through a covalent attachment to the reactive cysteine residue. METHODS: One of the FLICAs, FAM-DEVD-fmk, was used to monitor apoptosis progression in leukemic JURL-MK1 cells by means of flow cytometry. The effects of unlabeled caspase inhibitors z-DEVD-fmk and z-VAD-fmk on FLICA staining were analyzed to evaluate the contribution of caspase-bound FLICA to the fluorescent signal. Covalent binding of inhibitors to caspase-3 subunit was revealed by Western blotting. RESULTS: Although the unlabeled inhibitors irreversibly bind to caspase-3, completely inhibit its activity, and prevent FLICA binding to caspase-3 even at concentrations lower than 5 muM, they have no effect on FLICA staining of apoptotic cells. CONCLUSIONS: Fluorescent signal of FLICA is characteristic for apoptotic cells but originates mainly from yet unspecified site(s) that differ from the caspase active site. This finding puts in doubt the specificity of staining by various FLICAs with regard to individual caspases and shows the need for an extreme care in the interpretation of data obtained using these labels. Copyright 2007 International Society for Analytical Cytology.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a chloromethylketony aminokyselin $x analýza $x farmakologie $x metabolismus $7 D000590
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a kaspasa 3 $7 D053148
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a fluorescenční barviva $x analýza $x metabolismus $7 D005456
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a propidium $7 D011419
- 650 _2
- $a posttranslační úpravy proteinů $x účinky léků $7 D011499
- 650 _2
- $a podjednotky proteinů $x metabolismus $7 D021122
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a barvení a značení $7 D013194
- 650 _2
- $a substrátová specifita $7 D013379
- 650 _2
- $a inhibitory kaspas $7 D061945
- 700 1_
- $a Grebeňová, Dana $7 xx0115458
- 700 1_
- $a Hrkal, Zbyněk, $d 1934- $7 xx0059987
- 773 0_
- $w MED00013935 $t Cytometry. Part A $g Roč. 71, č. 8 (2007), s. 605-611 $x 1552-4922
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100114083259 $b ABA008
- 991 __
- $a 20120910174308 $b ABA008
- 999 __
- $a ok $b bmc $g 704723 $s 567289
- BAS __
- $a 3
- BMC __
- $a 2007 $b 71 $c 8 $d 605-611 $i 1552-4922 $m Cytometry. Part A $x MED00013935
- LZP __
- $a 2010-b1/vtme